Family-Based Association Study of the Serotonin-6 Receptor Gene (C267T Polymorphism) in Schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 126 B, Issue 1, 2004, Pages 10-15

  Dubertret, Caroline ^a,b   Hanoun, N ^b   Ades J ^a   Hamon, M ^b   Gorwood, P ^a,c  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Age at onset; Family history; HRR; Schizophrenia; TDT; Treatment response

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CYSTEINE; SEROTONIN 6 RECEPTOR; THREONINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CHILD; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESPONSE; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; LIMBIC SYSTEM; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 1842591997     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20120     Document Type: Article

References (35)

1. Aghajanian GK, Marek GJ. 2000. Serotonin model of schizophrenia: Emerging role of glutamate mechanisms. Brain Res Brain Res Rev 31:302-312.
2. American Psychiatric Association DSM-IV. 1994. Diagnostic and statistical manual of mental disorder. 4th edn. Washington, DC: APA.
3. Andreasen NC, Endicott J, Spitzer RL, Winokur G. 1977. The family history method using diagnostic criteria: Reliability and validity. Arch Gen Psychiatry 34:1229-1232.
4. Andreasen NC, Olsen S. 1982. Negative v. positive schizophrenia: definition and validation. Arch Gen Psychiatry 39:789-794.
5. Arimani T, Itokawa M, Aoti J, Schibuya H, Ookubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Toru M. 1996. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am J Med Genet 67:133-138.
6. Chiu HJ, Wang YC, Liou JH, Chao CH, Lee H, Tsai KY, Liu WC. 2001. Serotonin-6 receptor polymorphism in schizophrenia: Frequency, age at onset and cognitive function. Neuropsychobiology 43:113-116.
7. Csernansky JG, Murphy GM, Faustman WO. 1991. Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biol Psychiatry 30:383-400.
8. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J. 2001. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr Res 49:203-212.
9. East SZ, Burnet PW, Leslie RA, Roberts JC, Harrison PJ. 2002. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: Autoradiographic studies with [125I]SB-258585. Synapse 45:191-199.
10. Falk CT, Rubinstein P. 1987. Haplotype relative risk: An easy reliable way to construct a proper control sample for risk calculation. Ann Hum Gen 51:227-233.
11. Gorwood P. 1999. Genetic association studies in behavioral neuroscience In: Cruzio W, Gerlai R, editors. Molecular genetic techniques for behavioural neuroscience. Amsterdamk: Elsevier. pp 113-121.
12. Gorwood P, Leboyer M, Jay M, Payan C, Feingold J. 1995. Gender and age at onset in schizophrenia: Impact of family history. Am J Psychiatry 152:208-212.
13. Grimaldi B, Bonnin A, Fillion MP, Ruat M, Traiffort E, Fillion G. 1998. Characterization of 5-ht6 m-RNA in the rat brain during ontogenetic development. Naunyn-Schmiedeberg's. Arch Pharmacol 357:393-400.
14. 6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse 23:164-173.
15. 6 receptor-like material in the rat central nervous system. Brain Res 746:207-219.
16. Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW. 1996. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 66:47-56.
17. Lesch KP, Mossner R. 1998. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopment, and neurodegenerative disorders? Biol Psychiatry 44:179-192.
18. Masellis M, Basile VS, Meltzer HY, Lieberman JA, Sevy S, Goldman DA, Hamblin MW, Macciardi FM, Kennedy JL. 2001. Lack of association between the T→C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr Res 47:49-58.
19. May PR, Dencker SJ, Hubbard JW, Midha KK, Liberman RP. 1988. A systematic approach to treatment resistance in schizophrenic disorders. In: Dencker S, Kulhanel F, editors. Treatment resistance in schizophrenia. Wiesbaden: Vieweg Verlag.
20. Meltzer HY. 1999. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21:106S-115S.
21. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. and collaborators from the NIMH Genetics Initiative. 1994. Diagnostic interview for genetic studies, rationale, unique features, and training. Arch Gen Psychiatry 51:849-859.
22. Ohmori O, Shinkai T, Hori H, Nakamura J. 2001. Novel polymorphism in the 5′-upstream region of the human 5-HT6 receptor gene and schizophrenia. Neurosci Lett 310:17-20.
23. Otts J. 1989. Statistical properties of the haplotype relative risk. Genet Epidemiol 6:127-130.
24. Pouzet B, Didriksen M, Arnt J. 2002. Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol Biochem Behav 71:635-643.
25. Prasad S, Semwal P, Deshpande S, Bhatia T, Nimgaonkar VL, Thelma BK. 2002. Molecular genetics of schizophrenia: Past, present and future. J Biosci 27:35-52.
26. Rao PA, Pickar D, Gejman PV, Ram A, Gershon ES, Gelernter J. 1994. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch Gen Psychiatry 51:912-917.
27. Roberts JC, Reavill C, East SZ, Harrison PJ, Patel S, Routledge C, Leslie RA. 2002. The distribution of 5-HT(6) receptors in rat brain: An autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585. Brain Res 934:49-57.
28. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma JR, Shen Y, Meltzer HY, Sibley DR. 1994. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 193:1403-1410.
29. 6 receptor gene in schizophrenia. Am J Med Genet 88:120-122.
30. Spielman RS, Ewens WJ. 1996. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 59:983-989.
31. Spielman RS, McInnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
32. Tsai SJ, Chiu HJ, Wang YC, Hong CJ. 1999. Association study of the serotonin-6 receptor (C267T) variant with schizophrenia and aggressive behaviour. Neurosci Lett 271:135-137.
33. 6] receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 96:217-221.
34. Woolf B. 1955. On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
35. Yu WY, Tsai SJ, Lin CH, Hsu CP, Yang KH, Hong CJ. 1999. Serotonin-6 receptor variant (C267T) and clinical response to clozapine. Neuroreport 10:1231-1233.